Form 4 for ABCL AbCellera Biologics Inc.
Accepted 2023-05-26 00:00:00 ET · period of report 2023-05-26 · accession 0001209191-23-032484 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-26 | 2023-05-26 | ABCL | Booth Andrew | CFO | P - Purchase | $6.85 | +14.5K | 153.0K | +10% | +$99.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2023-05-26 | P | A | 14,500 | $6.85 | 153,000 | D | — | — |